Insider · CIK 0001896415
Sonja Banks
Files at FULC (Fulcrum Therapeutics, Inc.). First filing -, latest -.
In brief
Sonja Banks files SEC Form 4 as director at FULC (Fulcrum Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Sonja Banks has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | FULC Fulcrum Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +32,000 | $0.00 | $0 | 32,000 | Jul 2, 2026 |
| Jun 26, 2025 | FULC Fulcrum Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +36,000 | $0.00 | $0 | 36,000 | Jun 30, 2025 |
Questions about Sonja Banks
Answered from the filings on this page, as of the latest one.
Is Sonja Banks buying or selling?
Sonja Banks has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Sonja Banks's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Sonja Banks has 0.
Where does Sonja Banks file Form 4?
Sonja Banks has filed Form 4 at FULC (Fulcrum Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.